- Previous Close
7.36 - Open
7.42 - Bid 7.31 x 100
- Ask 7.42 x 100
- Day's Range
7.31 - 7.47 - 52 Week Range
5.42 - 11.41 - Volume
72,793 - Avg. Volume
480,468 - Market Cap (intraday)
447.961M - Beta (5Y Monthly) 1.33
- PE Ratio (TTM)
-- - EPS (TTM)
-1.34 - Earnings Date Feb 20, 2025 - Feb 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
11.54
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
www.healthcatalyst.com1,300
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HCAT
View More
Performance Overview: HCAT
Trailing total returns as of 11/21/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HCAT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HCAT
View MoreValuation Measures
Market Cap
447.84M
Enterprise Value
424.91M
Trailing P/E
--
Forward P/E
21.01
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.44
Price/Book (mrq)
1.26
Enterprise Value/Revenue
1.41
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-26.20%
Return on Assets (ttm)
-5.26%
Return on Equity (ttm)
-21.46%
Revenue (ttm)
302.06M
Net Income Avi to Common (ttm)
-79.14M
Diluted EPS (ttm)
-1.34
Balance Sheet and Cash Flow
Total Cash (mrq)
387.26M
Total Debt/Equity (mrq)
102.62%
Levered Free Cash Flow (ttm)
24.03M
Research Analysis: HCAT
View MoreCompany Insights: HCAT
HCAT does not have Company Insights
Research Reports: HCAT
View MoreDaily – Vickers Top Buyers & Sellers for 05/15/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 11/15/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 09/09/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 08/22/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.